Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIBIM: Aflibercept Treat-and-Extend for DME
NCT02788877Phase 4Unknown
- Sponsor
- Pusan National University Hospital
- Start
- Apr 2016
- Primary completion
- Sep 2019
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of aflibercept in diabetic macular edema (DME), sponsored by Pusan National University Hospital. Status: unknown.
02
Drugs
aflibercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02788877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02788877.